The current funding landscape is an opportunity for real-world evidence (RWE) to demonstrate its value and capabilities, especially as public funding solutions become more constrained. In this article, Atropos Health CEO and Co-Founder Dr. Brigham Hyde shares insights on how RWE can bridge gaps in healthcare research, especially when traditional funding avenues face challenges. Dr. Hyde highlights Atropos Health’s approach to generating novel, personalized evidence by enabling physicians and researchers to conduct real-world observational studies rapidly using existing clinical data.
Can real-world evidence bear some of the burden left by NIH cuts? Atropos Health’s CEO sees an opportunity.
